• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Poll

POLL: Should COVID-19 Vaccinations be Required at Conferences?

Author(s):

Dermatology Times Staff

Click here to answer this week's poll.

Yes
No

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
Related Content
Dual Inhibitor TRIV-509 Shows Promise for Rapid Improvement in Atopic Dermatitis
May 13th 2025

Dual Inhibitor TRIV-509 Shows Promise for Rapid Improvement in Atopic Dermatitis

ReV Up Your Vitiligo Treatment Strategies
December 19th 2023

ReV Up Your Vitiligo Treatment Strategies

Artax Presents Phase 2a Results of AX-158 for Plaque Psoriasis
May 9th 2025

Artax Presents Phase 2a Results of AX-158 for Plaque Psoriasis

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
March 26th 2022

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

Exclusive: Outgoing AAD President Seemal Desai, MD, FAAD, on the 3 Issues That Will Shape Dermatology in 2025 (& Beyond)
April 24th 2025

Exclusive: Outgoing AAD President Seemal Desai, MD, FAAD, on the 3 Issues That Will Shape Dermatology in 2025 (& Beyond)

Amy Paller, MD, MS, Discusses Phase 3 Trial Results for Qtorin 3.9% Rapamycin Gel
April 23rd 2025

Amy Paller, MD, MS, Discusses Phase 3 Trial Results for Qtorin 3.9% Rapamycin Gel

© 2025 MJH Life Sciences

All rights reserved.